What Is Elmiron
Elmiron (pentosan polysulfate sodium) is a drug that is used to treat a condition called interstitial cystitis, which is bladder inflammation or irritation. Elmiron functions like an anticoagulant (blood thinner) that prevents the formation of blood clots. Elmiron is used to treat chronic bladder discomfort and pain caused by cystitis. However, in June 2020 the drug manufacturer updated the product labeling and disclosed critical information concerning the potential risks of using the drug Elmiron. Furthermore, this disclosure of the drug Elmiron is significantly overdue concerting the individuals who have already suffered serious eye damage as a result from taking Elmiron.
Dangers and Side Effects of ELMIRON
Common dangers of taking this drug has been linked to the following diseases:
- Pigmentary maculopathy
- Macular degeneration
- Retinal maculopathy
Elmiron has also been known to cause other severe consequences affecting vision including: Difficulty reading, vision impairment, difficulty adapting to dim lighting, blurred vision (often centrally in the patient’s field of vision), dark spots in the center of vision, straight lines appearing curved or squiggly, muted or less vivid colors, and even blindness.
“Is this medicine used to treat predominantly women or men?”
-This medicine is mainly used to treat women but is also sometimes prescribed to men as well.
“How long before on this medication do patients typically start seeing these dangerous side effects?”
-This Mass Tort centers on use for 1 year or more of the drug ELMIRON.
“What is maculopathy?”
-Maculopathy is a serious disease that results in the loss of vision and significant retina damage.
“How does ELMIRON cause eye disease?
In 2018, researchers at the Emory Eye Center at the Emory School of Medicine in Atlanta, GA, announced that taking Elmiron can result in maculopathy.
Researchers revealed that all patients in the study showed signs of retinal disease and that the youngest patient in the study was diagnosed with interstitial cystitis at 23 years of age. That patient began taking Elmiron daily and began showing visual symptoms (difficulty with near vision as well as reading) by the age of 30.
American Academy of Ophthalmology. (2019, October 12). More evidence linking common bladder medication to a vision-threatening eye condition: New study shows about a quarter of patients with significant exposure to the drug show signs of retinal damage. ScienceDaily. Retrieved August 13, 2020 from www.sciencedaily.com/releases/2019/10/191012141218.htm
“Is there any legal options regarding potential Elmiron retina damage?”
-If an individual has used Elmiron bladder medication and has suffered retina damage or other eye injuries as a result of Elmiron, they may be entitled to significant financial compensation.
If you or a loved one have suffered from this dangerous medication, contact us.
Contact an Experienced Attorney — Get a Free Case Evaluation
With over three and a half decades of experience, the law firm of Rudolph F.X. Migliore, P.C. is positioned to help those who have been harmed by these medications. Our law firm works with nationally recognized associated firms to reach major verdicts and settlements. Call our New York office at (631) 543-3663 to arrange a no cost, no obligation consultation to find out how an attorney can help you.